Why the study?
Does saralasin induce renal vasoconstriction via the sympathetic nervous system in subjects with mild essential hypertension and dog models?
Does saralasin induce renal vasoconstriction via the sympathetic nervous system in subjects with mild essential hypertension and dog models?
Renal vasoconstriction induced by intravenous saralasin is partially mediated by the sympathetic renal nerves.
Supports sympathetic mediation of saralasin renal effects in models; hypothesis-generating and should not yet change practice.
The mechanism of renal vasoconstriction produced by saralasin and its dependence on the sympathetic nervous system was investigated in subjects with mild essential hypertension and in anaesthetized dogs. Fluid or saline was given to maximize agonist vasoconstrictor responses. The changes in renal haemodynamics produced by intravenously infused saralasin (dose 0.01-10 microgram kg-1 min-1) were assessed by clearance methods. In the patients, it induced a dose-related renal vasoconstriction which correlated with a rise in plasma noradrenaline levels. In dogs with innervated kidneys it also caused vasoconstriction. But in dogs with denervated kidneys it caused vasodilatation. Infusion at the highest dose directly into the renal artery of denervated kidneys induced only vasodilatation. We conclude that one component of the renal vasoconstriction that occurs with intravenous saralasin infusions is mediated by the renal nerves.
No takes yet. Share an insight, caveat, or question.
Wilcox et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: